QuickView for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=E2A3C22131A0F4274C97665DE133CC3D;jsessionid=A0C378E8C677CAA6DDC446AD5614384B;jsessionid=0E2145AAC980BC838BDE1A65BF4D08FB (gene)

1. An electrophilic fragment screening for the development of small molecules targeting caspase-2.
2. Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis.
3. Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias.
4. Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Model…
5. Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.

There were no clinical trials for CASP-2;jsessionid=5DEB2FCE89368D47002682B883EC5C23;jsessionid=E2A3C22131A0F4274C97665DE133CC3D;jsessionid=A0C378E8C677CAA6DDC446AD5614384B;jsessionid=0E2145AAC980BC838BDE1A65BF4D08FB